Drugs of Abuse Screen - Stimulant Amines - Urine
0090302
Ordering Recommendation
 
Mnemonic
U AMP
Methodology
Enzyme Immunoassay
Performed
Sun-Sat
Reported
Within 24 hours  
New York DOH Approval Status
This test is New York DOH approved.
Submit With Order
Specimen Required
Patient Preparation
  
Collect
Random urine.  
Specimen Preparation
Mix well. Transfer 4 mL urine to an ARUP Standard Transport Tube. (Min: 1 mL)  
Storage/Transport Temperature
Frozen. Also acceptable: Room temperature or refrigerated.  
Unacceptable Conditions
Specimens exposed to repeated freeze/thaw cycles.  
Remarks
  
Stability
Ambient: 1 week; Refrigerated: 5 days; Frozen: 3 years  
Reference Interval
Negative  
Interpretive Data
This test detects d-amphetamine, d-methamphetamine, methylenedioxyamphetamine (MDA), and methylenedioxymethamphetamine (MDMA) in human urine. It does not detect l-ephedrine, d-ephedrine, d-pseudoephedrine, l-pseudoephedrine, and phenylpropanolamine. Results greater than or equal to the 1000 ng/mL cutoff are positive. This is a screening test, results are unconfirmed and should be used for medical (treatment) purposes only.  
Note
 
CPT Code(s)
80101
Components
Component Test Code*Component Chart NameLOINC
0090302Stimulant Amines Detection3349-8
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • Amphetamine, qualitative urine
  • methamphetamine screen
  • Stimulant Amines tox screen
  • Stimulantss urine tox screen
  • Substance abuse screening